Syndax Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
SNDX on Nasdaq
Location
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA

Insiders trading volume in the past year

Syndax Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael A. Metzger Chief Executive Officer, Director $9.99M -$206K -2.02% Feb 10, 2025
Steve M. Sabus Chief Commercial Officer $5.69M Dec 5, 2022
Dennis Podlesak Director $3.84M Feb 5, 2025
Keith A. Goldan Chief Financial Officer $3.03M -$33.5K -1.1% Feb 10, 2025
Neil Gallagher President, Head of R&D $2.94M -$71.6K -2.38% Feb 10, 2025
Catherine Madigan Chief Medical Officer $2.84M Feb 2, 2023
Pierre Legault Director $1.8M Feb 5, 2025
Keith Katkin Director $1.8M Feb 5, 2025
Jennifer Jarrett Director $1.8M Feb 5, 2025
William Meury Director $1.8M Feb 5, 2025
Martin H. Huber Jr. Director $1.48M Feb 5, 2025
Aleksandra Rizo Director $1.28M Feb 5, 2025
Michael L. Meyers SVP, Chief Medical Officer $874K Feb 2, 2022
Briggs Morrison Director $636K Feb 7, 2024
Fabrice Egros Director $584K Feb 2, 2022
Alexander Nolte Chief Accounting Officer $439K Feb 2, 2023
Peter Ordentlich Chief Scientific Officer Feb 15, 2023

Recent Insider Transactions by Companies or Individuals for Syndax Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.